³Ô¹ÏÍøÕ¾

Latest ovarian cancer News | Page 4

Gene mutations should be tested routinely for ovarian cancer, say scientists
Catholic hospitals warn surgeries will be cancelled if Morrison Gov’s dud deal remains
Lynparza in combination with bevacizumab, and as monotherapy, demonstrates clinically meaningful survival benefit
Working to deliver world-class cancer research and care for all Tasmanians
PBS listing for ovarian cancer and kidney disease
Sugar modifications key to unlocking ovarian cancer secrets
Ovarian Cancer Therapy Zejula Newly Funded by Government
AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022
World-first preventive DNA screening for cancer and heart disease risk
Chemist aims to improve diagnosis of disease one protein molecule at time
UQ research recognised in national biomedical incubator
Pat Morin appointed deputy scientific director of Ludwig Institute for Cancer Research
Imfinzi plus chemotherapy significantly improved pathologic complete response in AEGEAN Phase III trial
COVID can’t stop cancer pioneer finishing his Ride4Research
Bone loss medicines linked to lower ovarian cancer rates
Queen’s Birthday honours for rare cancers researcher and clinician
AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
Grateful city recognises 2022 volunteers
“I’m very grateful” – Anne’s story of hope and ovarian cancer
Ludwig MSK study modeling tumor evolution reveals vulnerability for cancer prevention and therapy
World Ovarian Cancer Awareness Day: 7 symptoms to take seriously
New GP blood test could help diagnose ovarian cancer faster and more accurately, according to research funded by Wellbeing of Women
INOViQ announces manufacturing agreement with MP Biomedicals
Cancer pioneer Simon Chu’s Ride4Research
UNSW researcher receives prestigious NHMRC award
Pharmac deal good news for New Zealanders
Endometriosis and ovarian cancer genetically tied
University launches bioscience showcase for British Science Week
Shining light on our youngest ovarian cancer patients
Exercise trial aims to help women with recurrent ovarian cancer
University turns teal to raise awareness of ovarian cancer
Funding boost for ovarian cancer research
Grants support critical and otherwise unfunded ovarian cancer research
Turning Tassie Teal for Ovarian Cancer Awareness Month
Increased funding for ovarian cancer care and support
Ovarian cancer’s advance slowed by drug
Cervical samples could reveal risk of breast and ovarian cancer
Ovarian cancer survivor gets behind cancer research
February is Ovarian Cancer Awareness Month
Male carriers of BRCA1 and BRCA2 gene mutation also at risk of multiple cancers: study
TGA Approves NEW Advanced Ovarian Cancer Treatment for Women Living with Deadly Disease
Providing another option for newly diagnosed women with this deadly disease
Prostate cancer in Australia – what do numbers tell us?
Prime time: First therapeutic clinical trial of C’Dots underway
Lynparza granted Priority Review in US for BRCA-mutated HER2-negative high-risk early breast cancer
New BARD1 exosome liquid biopsy agreement with Griffith University
Unsung gene is key to how antibodies develop: University of Toronto study
Ludwig Lausanne team devises method to selectively grow tumor-targeting T cells for cancer therapy